{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:02:43Z","timestamp":1791302563082,"version":"4.1.0"},"reference-count":27,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer pharmaceuticals","doi-asserted-by":"publisher","award":["61034227"],"award-info":[{"award-number":["61034227"]}],"id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Transthyretin cardiac amyloidosis (ATTR-CM) is an underdiagnosed severe cardiomyopathy in older adults. Current diagnostic strategies rely on clinical \u2018red flags\u2019, but data on systematic screening in minimally selected populations remain limited. We aimed to describe the prevalence of ATTR-CM among cardiology inpatients with left ventricular hypertrophy (LVH) and to identify parameters associated with its diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>This prospective single-centre study included consecutive patients aged \u226560 years hospitalized in cardiology with echocardiographic LVH (wall thickness \u226512\u2005mm), irrespective of aetiology. Patients with known amyloidosis, prior heart transplantation, or contraindication to scintigraphy were excluded. All patients underwent immunologic testing and technetium-99\u2005m scintigraphy. ATTR-CM was diagnosed by cardiac uptake (Perugini grade \u22652) without significant monoclonal gammopathy. Multivariable logistic regression identified independent associations, and receiver-operating characteristic curve analysis assessed diagnostic performance. Between October 2021 and June 2023, ATTR-CM was diagnosed in 29 of 400 patients (7.3%). Four variables were independently associated with ATTR-CM: basal longitudinal strain (BLS) (odds ratio [OR] 0.84, 95% CI 0.74\u20130.95), non-sinus rhythm (OR 3.85, 95% CI 1.30\u201311.11), bilateral carpal tunnel syndrome (OR 3.48, 95% CI 1.09\u201311.14), and history of stroke (OR 8.67, 95% CI 2.65\u201328.34). BLS showed the highest discrimination for ATTR-CM (AUC 0.81). During a median follow-up of 3.31 years, all-cause mortality did not significantly differ between ATTR-CM and non-ATTR-CM patients (P = 0.137).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In a minimally selected cardiology population with LVH, systematic screening identified a substantial prevalence of ATTR-CM. BLS may help prioritize diagnostic testing in routine practice and facilitate earlier identification and management of ATTR-CM.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeag254","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:19:02Z","timestamp":1789384742000},"source":"Crossref","is-referenced-by-count":0,"title":["Prospective systematic screening for transthyretin amyloid cardiomyopathy in cardiology inpatients with left ventricular hypertrophy: the IMPACT study"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-2873","authenticated-orcid":false,"given":"Benjamin","family":"Alos","sequence":"first","affiliation":[{"name":"Cardiology Department, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86021 ,","place":["France"]},{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Beard","sequence":"additional","affiliation":[{"name":"Cardiology Department, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86021 ,","place":["France"]},{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Khalifa","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Polyclinic of Poitiers , SINEM, 1 Rue de la Providence, Poitiers 86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, CHU Poitiers , Poitiers F-86021 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-4252","authenticated-orcid":false,"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Boucher","sequence":"additional","affiliation":[{"name":"Cardiology Department, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86021 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5942-9964","authenticated-orcid":false,"given":"Lisa","family":"Durocher","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Grosdenier","sequence":"additional","affiliation":[{"name":"Biological Resource Center (BRC BB-0033-00068), CHU Poitiers , Poitiers F-86021 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3301-2862","authenticated-orcid":false,"given":"Maxime","family":"Doublet","sequence":"additional","affiliation":[{"name":"Clinityx Company , Biostatistics Department, 137 Rue d'Aguesseau, Boulogne-Billancourt F-92100 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Proust","sequence":"additional","affiliation":[{"name":"Institut de Cardiologie, H\u00f4pital Piti\u00e9-Salp\u00eatri\u00e8re, AP-HP (Assistance Publique-H\u00f4pitaux de Paris) , Paris 75013 ,","place":["France"]},{"name":"ACTION Study Group \u00a0 Paris, Institut de Cardiologie, H\u00f4pital Piti\u00e9-Salp\u00e9tri\u00e8re, 47 Boulevard de l'H\u00f4pital, Paris 75013 ,","place":["France"]},{"name":"INSERM UMRS 1166-ICAN (Institute of CardioMetabolism and Nutrition), Sorbonne Universit\u00e9 , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc-Philippe","family":"Christiaens","sequence":"additional","affiliation":[{"name":"Cardiology Department, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86021 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ragot","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-0093","authenticated-orcid":false,"given":"Claire","family":"Bouleti","sequence":"additional","affiliation":[{"name":"Cardiology Department, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86021 ,","place":["France"]},{"name":"Clinical Investigation Center CIC 1402, University of Poitiers, INSERM, CHU Poitiers , 2, Rue de la Mil\u00e9trie, Poitiers F-86000 ,","place":["France"]},{"name":"FACT network (French Alliance for Cardiovascular Trials) , H\u00f4pital Bichat, 46 Rue Henri Huchard, Paris 75018 ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"2026100611462801500_jeag254-B1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/eurjpc\/zwae093","article-title":"Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study","volume":"31","author":"Aimo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2026100611462801500_jeag254-B2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2019.12.063","article-title":"Diagnostic delay in wild type transthyretin cardiac amyloidosis - A clinical challenge","volume":"304","author":"Ladefoged","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026100611462801500_jeag254-B3","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/13506129.2018.1498782","article-title":"Seven factors predict a delayed diagnosis of cardiac amyloidosis","volume":"25","author":"Bishop","year":"2018","journal-title":"Amyloid"},{"key":"2026100611462801500_jeag254-B5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026100611462801500_jeag254-B6","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonzalez-Lopez","year":"2015","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B7","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B8","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/ehf2.14971","article-title":"Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy","volume":"11","author":"Garcia-Pavia","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2026100611462801500_jeag254-B9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/13506129.2024.2398446","article-title":"International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction","volume":"31","author":"Yun","year":"2024","journal-title":"Amyloid"},{"key":"2026100611462801500_jeag254-B10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jacc.2019.04.054","article-title":"Association of carpal tunnel syndrome with amyloidosis, heart failure, and adverse cardiovascular outcomes","volume":"74","author":"Fosbol","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026100611462801500_jeag254-B11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.acvd.2025.07.014","article-title":"Rationale and design of the imaging for detection rate of cardiac transthyretin amyloidosis study (the IMPACT study)","volume":"119","author":"Beard","year":"2026","journal-title":"Arch Cardiovasc Dis"},{"key":"2026100611462801500_jeag254-B12","first-page":"e000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026100611462801500_jeag254-B13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/13506129.2017.1333956","article-title":"Diagnostic score for the detection of cardiac amyloidosis in patients with left ventricular hypertrophy and impact on prognosis","volume":"24","author":"Cariou","year":"2017","journal-title":"Amyloid"},{"key":"2026100611462801500_jeag254-B14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacep.2023.11.015","article-title":"Prevalence and treatment of atrial fibrillation and flutter in cardiac amyloidosis","volume":"10","author":"Haslett","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026100611462801500_jeag254-B15","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/joim.20042","article-title":"Wild-type transthyretin cardiac amyloidosis and aortic stenosis: can carpal tunnel syndrome help distinguish the chicken from the egg?","volume":"297","author":"Delbarre","year":"2025","journal-title":"J Intern Med"},{"key":"2026100611462801500_jeag254-B16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B17","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1002\/ehf2.15311","article-title":"Delays in diagnosis and treatment of ATTR cardiac amyloidosis: a real-world data analysis","volume":"12","author":"Vogel","year":"2025","journal-title":"ESC Heart Fail"},{"key":"2026100611462801500_jeag254-B18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/ejhf.2504","article-title":"Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from phase 2 of the AC-TIVE study, an Italian nationwide survey","volume":"24","author":"Merlo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2026100611462801500_jeag254-B19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026100611462801500_jeag254-B21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ehjci\/jeaf282","article-title":"Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy in 2025. A clinical consensus statement of the European association of cardiovascular imaging (EACVI) of the ESC","volume":"27","author":"Cardim","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026100611462801500_jeag254-B22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/echo.15626","article-title":"Echocardiographic score for the screening of cardiac amyloidosis with positive 99\u2005m technetium pyrophosphate scintigraphy result","volume":"40","author":"Nagai","year":"2023","journal-title":"Echocardiography"},{"key":"2026100611462801500_jeag254-B23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014645","article-title":"Optimal echocardiographic parameters to improve the diagnostic yield of tc-99m-bone avid tracer cardiac scintigraphy for transthyretin cardiac amyloidosis","volume":"15","author":"Cuddy","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026100611462801500_jeag254-B24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"key":"2026100611462801500_jeag254-B25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1080\/13506129.2019.1625322","article-title":"Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders","volume":"26","author":"Lopez-Sainz","year":"2019","journal-title":"Amyloid"},{"key":"2026100611462801500_jeag254-B26","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","article-title":"Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation","volume":"41","author":"Scully","year":"2020","journal-title":"Eur Heart J"},{"key":"2026100611462801500_jeag254-B27","doi-asserted-by":"crossref","DOI":"10.1097\/GOX.0000000000006816","article-title":"Amyloidosis screening by biopsy during carpal tunnel release: a systematic review and meta-analysis","volume":"13","author":"Ferrin","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag254\/71083022\/jeag254.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeag254\/71083022\/jeag254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:46:35Z","timestamp":1791301595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article\/doi\/10.1093\/ehjci\/jeag254\/8795212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeag254","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"jeag254"}}